German pharma giant Boehringer Ingelheim launches €100m life science fund | AltAssets Private Equity News

Subscribe today

Advanced
Search

German pharma giant Boehringer Ingelheim launches €100m life science fund

1 Apr 2010

German pharmaceutical giant Boehringer Ingelheim has launched a corporate venture capital fund to stimulate innovation in the life sciences sector.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.